Immune Responses to H5N1 Vaccine With and Without MF59 Adjuvant
Conditions:   Influenza;   HealthyInterventions:   Biological: H5N1 vaccine plus MF59 adjuvant;   Biological: H5N1 vaccine without adjuvantSponsors:   National Heart, Lung, and Blood Institute (NHLBI);   Center for Human Immunology, Autoimmunity and Inflammation;   National Institutes of Health Clinical Center (CC)Completed - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2012 Category: Research Source Type: clinical trials

H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition:   InfluenzaInterventions:   Biological: H5N1 Vaccine;   Drug: ASO3 AdjuvantSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified October 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials

H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition:   InfluenzaInterventions:   Biological: H5N1 Vaccine;   Drug: ASO3 AdjuvantSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting - verified July 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials

H5N1 Vaccination With and Without AS03: Systems Biology Analysis
Condition:   InfluenzaInterventions:   Biological: H5N1 Vaccine;   Drug: ASO3 AdjuvantSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified October 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2012 Category: Research Source Type: clinical trials